Provided by Tiger Fintech (Singapore) Pte. Ltd.

XTL Biopharmaceuticals

1.16
+0.0000
Volume:564.00
Turnover:663.92
Market Cap:10.22M
PE:-5.53
High:1.16
Open:1.16
Low:1.16
Close:1.16
Loading ...
Apr 30, 2024

Annual Report

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 22, 2023

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 30, 2022

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
May 19, 2021

[Rev.]Annual Report

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 15, 2021

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Nov 25, 2020

important event

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Mar 12, 2020

Annual Report

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Jan 29, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Jan 22, 2020

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Jan 13, 2020

Report of foreign issuer

[Amend] Report of foreign issuer [Rules 13a-16 and 15d-16]
Dec 18, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Nov 27, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Oct 31, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Sep 04, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
May 30, 2019

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]
Dec 27, 2018

Report of foreign issuer

Report of foreign issuer [Rules 13a-16 and 15d-16]